Patients diagnosed with pancreatic cancer have a poor prognosis and new therapeutic approaches are urgently required. Now, the findings of a randomized phase IIb study provide a potential new first-line treatment regimen for patients with KRAS-wild-type advanced-stage and/or metastatic pancreatic cancer.Investigators selected the

中文翻译：

---

胰腺癌：EGFR抑制可有效对抗KRAS野生型疾病

被诊断为胰腺癌的患者预后较差，迫切需要新的治疗方法。现在，IIb期随机研究的结果为KRAS野生型晚期和/或转移性胰腺癌患者提供了潜在的一线治疗方案。